Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Ventral striatal neuroimmune signalling biases the expression of social memory in male mice.

Brain, behavior, and immunity·2026

Same author

Characteristics and outcomes of patients with pediatric-onset non-mastocytosis mast cell activation disorders: A CEREMAST study.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026

Same author

The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives.

Tumori·2025

Same author

Sarcopenic obesity and reduced BMD in young men living with HIV: body composition and sex steroids interplay.

Journal of endocrinological investigation·2024

Same author

Field output correction factors of small static field for IBA razor nanochamber.

Biomedical physics & engineering express·2023

Same author

Long-term trajectories of bone metabolism parameters and bone mineral density (BMD) in obese patients treated with metabolic surgery: a real-world, retrospective study.

Journal of endocrinological investigation·2023

Search research articles

Related Experiment Video

Updated: May 31, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Radionuclide therapy and integrated protocols for bone metastases.

S Chiacchio¹, S Mazzarri, A Lorenzoni

¹Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of

|July 9, 2011

Summary

Bone-seeking radiopharmaceuticals effectively palliate pain from bone metastases in cancer patients. These agents offer a favorable safety profile and significant clinical benefit, with potential for synergistic anti-tumor effects when combined with other therapies.

More Related Videos

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Experiment Videos

Last Updated: May 31, 2026

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on: April 24, 2020

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Area of Science:

Oncology
Nuclear Medicine
Palliative Care

Background:

Bone metastases cause significant morbidity and mortality in advanced cancers, particularly breast and prostate cancer (65-70% of patients).
Skeletal metastasis involves complex biological processes including cellular invasion, osteoclast/osteoblast stimulation, and mediation by cytokines and tumor-derived factors.
Pain from bone metastasis is primarily caused by cytokine-induced stimulation of sensory nerve endings.

Purpose of the Study:

To review the current use of bone-seeking radiopharmaceuticals for bone pain palliation.
To summarize indications, patient selection criteria, efficacy, and toxicity of these agents.
To review data on combination therapies involving radiopharmaceuticals for potential anti-tumor effects.

Main Methods:

Review of current literature and clinical experience with bone-seeking radiopharmaceuticals.
Focus on efficacy, toxicity, indications, and patient selection for palliative bone pain treatment.
Examination of combination therapies with chemotherapy and bisphosphonates.

Main Results:

Bone-seeking radiopharmaceuticals are effective for multiple blastic or mixed skeletal lesions, with a favorable toxicity profile and high clinical benefit rates (45-80% overall response, 10-30% complete response).
Palliative effects are attributed to targeted radiation of the bone marrow.
Combination therapies show encouraging results for potential synergistic anti-tumor efficacy.

Conclusions:

Bone-seeking radiopharmaceuticals are a valuable tool for managing bone pain in cancer patients.
These agents offer good palliation and a favorable safety profile, with potential for systemic anti-tumor effects.
Combination therapies may enhance anti-tumor efficacy beyond pain palliation.